We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
Cap. Flow
+$1.91B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$127M
2
CI icon
Cigna
CI
+$54M
3
CVS icon
CVS Health
CVS
+$38.8M
4
MPC icon
Marathon Petroleum
MPC
+$28.9M
5
FANG icon
Diamondback Energy
FANG
+$19M

Sector Composition

Rank Sector Weight
1 Technology 16.95%
2 Financials 15.85%
3 Healthcare 14.41%
4 Consumer Discretionary 10.13%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNRO icon
926
Monro
MNRO
$399M
$6.71M 0.01%
97,660
+16,364
+20% +$1.2M
REZI icon
927
Resideo Technologies
REZI
$5.49B
$6.7M 0.01%
+325,875
New +$6.96M
HI
928
DELISTED
Hillenbrand
HI
$6.68M 0.01%
176,251
+31,677
+22% +$1.45M
KBR icon
929
KBR
KBR
$4.68B
$6.68M 0.01%
440,127
+179,161
+69% +$3.35M
ITGR icon
930
Integer Holdings
ITGR
$4.23B
$6.67M 0.01%
87,495
+15,979
+22% +$1.28M
HMSY
931
DELISTED
HMS Holdings Corp.
HMSY
$6.66M 0.01%
236,807
+41,526
+21% +$1.34M
JBTM
932
JBT Marel
JBTM
$7.41B
$6.63M 0.01%
92,311
+15,958
+21% +$1.41M
IRBT
933
DELISTED
iRobot
IRBT
$6.62M 0.01%
79,103
+14,121
+22% +$1.28M
ALNY icon
934
Alnylam Pharmaceuticals
ALNY
$29.5B
$6.61M 0.01%
90,596
-5,849
-6% -$450K
HDS
935
DELISTED
HD Supply Holdings, Inc.
HDS
$6.61M 0.01%
176,038
-2,392
-1% -$92.1K
GWRE icon
936
Guidewire Software
GWRE
$13.1B
$6.56M 0.01%
81,797
-2,869
-3% -$250K
QGEN icon
937
Qiagen
QGEN
$8.73B
$6.56M 0.01%
179,618
+5,253
+3% +$195K
SFNC icon
938
Simmons First National
SFNC
$3.45B
$6.56M 0.01%
271,794
+48,371
+22% +$1.3M
INGN icon
939
Inogen
INGN
$182M
$6.55M 0.01%
52,759
+18,131
+52% +$2.99M
R icon
940
Ryder
R
$10.1B
$6.55M 0.01%
136,007
+42,157
+45% +$2.42M
SAFM
941
DELISTED
Sanderson Farms Inc
SAFM
$6.55M 0.01%
65,961
+21,720
+49% +$2.22M
MRCY icon
942
Mercury Systems
MRCY
$6.35B
$6.53M 0.01%
138,127
+23,991
+21% +$1.17M
TKR icon
943
Timken Company
TKR
$9.85B
$6.53M 0.01%
174,909
+47,219
+37% +$1.91M
CLH icon
944
Clean Harbors
CLH
$16.4B
$6.49M 0.01%
131,560
+45,467
+53% +$2.83M
ARMK icon
945
Aramark
ARMK
$14.9B
$6.49M 0.01%
310,114
+7,494
+2% +$195K
KFY icon
946
Korn Ferry
KFY
$4.21B
$6.48M 0.01%
163,884
+28,320
+21% +$1.28M
WBD icon
947
Warner Bros
WBD
$65.4B
$6.46M 0.01%
261,097
-2,004
-0.8% -$61K
PDCO
948
DELISTED
Patterson Companies, Inc.
PDCO
$6.44M 0.01%
327,761
+99,987
+44% +$2.33M
EPC icon
949
Edgewell Personal Care
EPC
$1.27B
$6.42M 0.01%
171,971
+67,768
+65% +$2.96M
PRA
950
DELISTED
ProAssurance
PRA
$6.4M 0.01%
157,846
+27,391
+21% +$1.17M

Similar funds

RhumbLine Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.

  • RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
  • RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
  • RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
  • RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
  • RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
  • RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.